Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Releases
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Email Alerts
    • Contact IR

Press Releases

Press Releases

Recent Releases

May 16, 2022
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest

May 16, 2022
Athira Pharma Presents Preclinical Data at the 2022 Peripheral Nerve Society (PNS) Annual Meeting

May 12, 2022
Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates

Press Releases
October 1, 2020
Athira Pharma Announces Initiation of Patient Dosing for the LIFT-AD Study, a Phase 2/3 Clinical Trial to Evaluate ATH-1017 for Treatment of Mild-to-Moderate Alzheimer's Disease
September 22, 2020
Athira Pharma Announces Closing of Initial Public Offering
September 17, 2020
Athira Pharma Announces Pricing of Initial Public Offering
June 4, 2020
Athira Pharma Closes $85 Million Series B Financing
May 28, 2020
Athira Pharma to Present at Jefferies Virtual Global Healthcare Conference
December 9, 2019
Athira Pharma Presents Positive Data for NDX-1017 in Alzheimer's Patients at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference
November 20, 2019
Athira Pharma to Present Phase 1 Data for NDX-1017 in Oral Presentation at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference
October 2, 2019
Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer's Patients
July 16, 2019
Athira Pharma Presents Preliminary Results from Phase 1 Trial of NDX-1017 at Alzheimer's Association International Conference 2019 (AAIC)
July 11, 2019
Athira Pharma Announces Appointment of Mark Litton as Chief Operating Officer

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Next page next ›
  • Last page last »
Displaying 61 - 70 of 73
< SIGN UP FOR EMAIL ALERTS
CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

FCOI Policy

Privacy Policy

© Athira Pharma, Inc. All rights reserved.